Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease

By sjmartinez • April 28, 2023

Rastogi A, Januzzi JL Jr. Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease. J Clin Med. 2023 Apr 12;12(8):2824. doi: 10.3390/jcm12082824. PMID: 37109162.

Tags: cardiac remodeling, cardiovascular outcomes, Chronic kidney disease, glomerular pressure, heart failure, mechanism of action, Nephrology, Publications, renal outcomes, sodium-glucose cotransporter-2 inhibitors, sympathetic nervous system, Type 2 diabetes

Artificial intelligence in medicine and nephrology: hope, hype, and reality

Glassock RJ. Artificial intelligence in medicine and nephrology: hope, hype, and reality. Clin Kidney J. 2024 Mar 22;17(4):sfae074. doi: 10.1093/ckj/sfae074. PMID: 38618490; PMCID: PMC11015150.

Prognostic Scoring in IgA Vasculitis

Glassock RJ. Prognostic Scoring in IgA Vasculitis. Clin J Am Soc Nephrol. 2024 Apr 1;19(4):409-411. doi: 10.2215/CJN.0000000000000444. PMID: 38598194.

Elevation of Donor-derived Cell-free DNA Before Biopsy-proven Rejection in Kidney Transplant

Bromberg JS, Bunnapradist S, Samaniego-Picota M, Anand S, Stites E, Gauthier P, Demko Z, Prewett A, Armer-Cabral M, Marshall K, Kaur N, Bloom MS, Tabriziani[...]